17beta-estradiol (E2), acting via estrogen receptor (ER)-alpha, inhibits feeding in animals. One mechanism apparently involves an increase in the satiating potency of cholecystokinin (CCK) released from the small intestine by ingested food. For example, the satiating potency of intraduodenal lipid infusions is increased by E2 in ovariectomized rats; this increased satiation is dependent on CCK, and it is accompanied by increases in the numbers of ERalpha-positive cells that express c-Fos in a subregion of the caudal nucleus tractus solitarius (cNTS) that receives abdominal vagal afferent projections. To test whether direct administration of E2 to this area of the hindbrain is sufficient to inhibit food intake, we first implanted 0.2 microg estradiol benzoate (EB) in cholesterol or cholesterol alone either sc or onto the surface of the hindbrain over the cNTS. Food intake was significantly reduced after hindbrain EB implants but not after sc EB implants. Next we verified that equimolar hindbrain implants of E2 and EB had similar feeding-inhibitory effects and determined that only small amounts of E2 reached brain areas outside the dorsal caudal hindbrain after hindbrain implants of (3)H-labeled E2. Neither plasma estradiol concentration nor plasma inflammatory cytokine concentration was increased by either hindbrain or sc EB implants. Finally, hindbrain EB implants, but not sc implants, increased c-Fos in ERalpha-positive cells in the cNTS after ip injection of 4 microg/kg CCK-8. We conclude that E2, acting via ERalpha in cNTS neurons, including neurons stimulated by ip CCK, is sufficient to inhibit feeding.

Eating is modulated by estradiol in females of many species and in women. To further investigate the estrogen receptor mechanism mediating this effect, ovariectomized rats and mice were treated with estradiol benzoate or the estrogen receptor-alpha (ER-alpha)-selective agonist PPT. PPT inhibited eating in rats much more rapidly than estradiol (approximately 2-6 h versus >24 h). In contrast, the latencies to vaginal estrus after PPT and estradiol were similar (>24 h). PPT also inhibited eating within a few hours in wild-type mice, but failed to inhibit eating in transgenic mice deficient in ER-alpha (ERalphaKO mice). PPT, but not estradiol, induced the expression of c-Fos in corticotrophin-releasing hormone (CRH)-expressing cells of the paraventricular nucleus (PVN) of the hypothalamus within 90-180 min in rats. Both PPT and estradiol reduced c-Fos expression in an ER-alpha-containing area of the nucleus of the solitary tract. The anomalously rapid eating-inhibitory effect of PPT suggests that PPT's neuropharmacological effect differs from estradiol's, perhaps because PPT differentially activates membrane versus nuclear ER-alpha or because PPT activates non-ER-alpha membrane estrogen receptors in addition to ER-alpha. The failure of PPT to inhibit eating in ERalphaKO mice, however, indicates that ER-alpha is necessary for PPT's eating-inhibitory action and that any PPT-induced activation of non-ER-alpha estrogen receptors is not sufficient to inhibit eating. Finally, the rapid induction of c-Fos in CRH-expressing cells in the PVN by PPT suggests that PPT elicits a neural response that is similar to that elicited by stress or aversive emotional stimuli.

No abstract

This study aimed to determine the effect of dietary cation and anion difference (DCAD) on milk production and body fluid distribution in lactating dairy goats. Ten dairy goats were selected and divided into two groups, five animals each. Animals received either control DCAD (control, 22.81 mEq/100 g dry matter (DM)) or high DCAD (DCAD, 39.08 mEq/ 100 g DM). The results indicated that rectal temperature (Tr), respiration rate, milk yield and compositions did not differ between groups. But the percentage change of Tr from the DCAD group was lower than the control group between 09.00 and 13.00 hours. DM intake tended to increase in the DCAD group. Dairy goats in the DCAD group drank more water, but urinary excretion and plasma antidiuretic hormone concentration remained unchanged. Apparent water balance was higher from the DCAD group over 24 h. There was no effect of DCAD on plasma and blood volumes, but tended to increase in extracellular fluid and thereby increased total body water. The present results indicate that animals supplemented with high DCAD increase their total body water and apparent water balance. These results have contributed to the process of adaptation for evaporative cooling and would be useful in slowing down the elevation in Tr.

Blood pressure (BP) was measured in 31 renal azotaemic dogs by oscillometric measurement at the posterior tibia artery, and urine and blood samples were collected. Haematology, blood chemistry and urinalysis were performed and urinary protein:creatinine ratio (UPC) and fractional excretions of electrolytes (FE(e)) were calculated. The results showed that only 19% of dogs with renal azotaemia were hypertensive, whereas almost all of them had high urinary protein and electrolyte excretions. There was no association between BP, UPC and FE(e). A positive correlation was found between all pairs of electrolyte fractional excretions. When the severity of renal impairment was observed using plasma creatinine concentration, neither BP nor UPC was correlated. Only the FE( e ) was associated with the degree of azotaemia. The results suggest that dogs with renal azotaemia do not necessarily have hypertension. The fractional urinary excretion of electrolytes may be a good indicator for severity of renal dysfunction in azotaemic dogs.

The present study was conducted to evaluate the effects of long-term administration of recombinant bovine somatotropin (rbST) on the regulation of body fluids, mammary blood flow (MBF) and other variables relevant to milk synthesis, in crossbred dairy cattle (0·875 of Holstein–Friesian (HF) genes and 0·125 Red Shindi (RS) genes. Ten first lactation, non-pregnant, animals were chosen and divided into the control and experimental groups of five animals each. Four consecutive measurements were carried out in each group beginning on days 45 (pre-treatment), 105, 165 and 225 of lactation. Animals that had completed 60 days of lactation were injected subcutaneously every 14 days with 500 mg of rbST (POSILAC, Monsanto, USA) in the experimental group, while animals in the control group were injected subcutaneously every 14 days with 800 mg of sterile sesame oil, without rbST, as a control. All animals were fed with rice straw treated with 50 g urea/l as the source of roughage in combination with a similar concentrate throughout the experiments. During the treatment periods, the daily dry matter intake (DMI) was numerically greater for rbST-treated animals than for control animals, while the relative values of DMI per kg body weight and water intake showed no differences.Animals in both groups gained weight throughout the experiment with no significant differences between the groups. Animals receiving rbST for 45 days increased their peak milk yield from 13·4 kg/day per animal during pre-treatment to 15·9 kg/day per animal (18·7% increase) on day 105 of measurement and this peak yield was higher (19·5%) than those of control animals in the same period. Milk yields on days 225 in late lactation of both groups significantly decreased (P<0·05) in comparison with the early and mid-lactating periods. Over the course of the experiment, milk yield of the rbST-treated animals was significantly higher than those of the control animals (P<0·01). The administration of rbST significantly increased MBF (P<0·05) and mammary plasma flow (MPF) (P<0·01). The ratio of MBF to milk yield slightly increased as lactation advanced in both controls and rbST-treated animals. The administration of rbST significantly increased the absolute values of both plasma volume (P<0·01) and blood volume (P<0·05) when compared with the control animals. The control animals showed no significant changes in values of extracellular water (ECW) throughout the course of treatment periods. The rbST-treated animals increased in both the absolute values and the relative (proportion of body weight) values of ECW throughout the experiment (P<0·05). The estimated values of intracellular water (ICW) in both groups showed no significant changes during the course of treatments. There were no significant changes in the water turnover rate (WTO) and the biological half-life of tritiated water in different periods of lactation in both groups. The absolute values of total body water space (TOH) and total body water (TBW) were significantly greater in rbST-treated than control an...

SU MMARYThe objective of the study was to determine the in vivo relationship between the long-term administration of recombinant bovine somatotropin (rbST), circulating levels of IGF-I and insulin, mammary blood flow and other variables relevant to milk synthesis, in crossbred, Holstein cattle. Ten first-lactation, non-pregnant, crossbred, Holstein dairy cattle were divided into two groups of five animals each ; an experimental group and a control group. Animals in each group were fed with rice straw, treated with 5 kg urea dissolved in 100 litres water per 100 kg dry rice straw as the source of roughage. Four consecutive study periods were carried out in each group. These consisted of a pretreatment period (45 days postpartum before lactation peak) and three treatment periods during early lactation (105 days postpartum), mid-lactation (165 days postpartum) and late lactation (225 days postpartum). During the treatment periods, animals that had completed 60 days of lactation were injected subcutaneously at fortnightly intervals with 500 mg of recombinant bovine somatotropin (rbST) (POSILAC, Monsanto, USA) in the experimental group, while animals in the control group were injected subcutaneously at fortnightly intervals with 800 mg of sterile sesame oil, without rbST, as a placebo. During the pretreatment period, there were no significant differences in plasma concentrations of IGF-I, insulin and other parameters between the control group and the experimental group. During the treatment periods, the increase in the concentration of plasma IGF-I in rbST treated animals was significantly higher than in the control animals throughout the lactation period. Plasma glucose, protein and triglyceride concentrations in each group remained stable throughout the study. The total daily dry matter intakes were not significantly different between the groups. Milk yield increased by 20 % with rbST treatment and it was 22 % greater than that of the control animals receiving placebo in early lactation. Milk yield of rbST treated animals rose to a peak in early lactation and then gradually declined. In late lactation, milk yield of rbST-treated animals decreased by 19 % as compared with early lactation. Udder plasma flow and udder blood flow markedly increased with rbST treatment and there were no significant changes in the control animals. The ratio of udder blood flow to the rate of milk production increased in mid-and late lactation in controls and the rbST treated animals. These findings suggest that the short persistency of lactation in rbST treated animals was similar to that in the control animals receiving placebo. Changes in milk production during the progress of lactation in rbST treated animals might not be controlled systemically only but also locally within the mammary gland. The lack of effect of higher plasma IGF-I levels on persistency of lactation in rbST treated animals, may be due to changes in the pattern of IGF-I binding proteins and paracrine production inhibiting IGF-I action.

Background and Aim: The high salinity of drinking water has been a significant problem of the Mekong Rivers Delta. Animals drinking high salinity water altered feed and water intake (WI), urinary electrolytes excretion, and productivity. This study aimed to evaluate the effects of high salinity in drinking water on drinking and eating behaviors and kidney function in crossbred goats. Materials and Methods: The experiment was completely randomized with two treatments: freshwater (0%, seawater [SW0]) and water high in salinity (1.5%, SW1.5) from diluted SW, with five replicates (five animals per treatment). This experiment lasted 3 weeks: the 1st week for the pre-treatment period and the 2nd-3rd weeks for the post-treatment. Dry matter intake (DMI) and WI were recorded every day, while urine volume (UV) was determined from day 8 to day 21. Blood and urinary samples were collected on days 6, 14, and 21 of the study for electrolytes and creatinine analysis. Results: The results demonstrated that both DMI and WI were affected by SW1.5 (p<0.05). Goats drinking from SW1.5 had lower DMI during D19–21, and the ratio of DMI/WI was significantly different during D16–21 (p<0.05). Interestingly, the UV from SW1.5 was higher than that from SW0 during D13–21 (p<0.05). Although the body weights (BW) of both groups were similar (p>0.05), the weight gain observed in the SW1.5 group tended to decrease (p=0.056) at the 2nd week. The concentration of electrolytes in blood did not differ between the groups (p>0.05). In contrast, the concentration and excretion of Na+ and Cl- in urine increased in SW1.5 goats at D14 (p<0.05), while creatinine levels in the blood remained normal (p>0.05). Conclusion: The study concluded that crossbred male goats can tolerate 1.5% saline water from diluted SW for 2 weeks. The high salinity in water influences drinking and eating behavior in growing goats. However, the adaptive mechanism by increasing urine output and reducing the reabsorption of Na+ and Cl- in the kidney is the key function and works faster than behavioral responses. The kidney apparently drives drinking behavior during high salinity water consumption.